Skip to main content
Top
Published in: Rheumatology International 8/2009

01-06-2009 | Original Article

Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis

Authors: Franca Majone, Silvia Olivieri, Franco Cozzi, Anna Montaldi, Marta Tonello, Maria Serena Visentin, Luca Ciprian, Amelia Ruffatti

Published in: Rheumatology International | Issue 8/2009

Login to get access

Abstract

The sera of 39 patients (38 women and 1 man), 16 with limited and 23 with diffuse clinical form of systemic sclerosis (SSc), were tested for anti-centromere (ACA), anti-topoisomerase I (ATA) and anti-RNA polymerase III (ARA) antibodies. The presence of apoptotic cells in cultures of circulating lymphocytes was investigated using the TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling) technique. ACAs were present in 16 (41%), ATA in 15 (38%) and ARA in 8 (21%) cases. The mean frequency of apoptotic lymphocytes was statistically higher in the ARA positive patients with respect to that in the control population (P < 0.001), in ACA (P < 0.001) and in the ATA (P < 0.001) groups. Moreover, apoptosis was distributed homogenously in ACA and ATA positive subjects, but not in the ARA patients. Our results show that there is an increase in apoptosis in the lymphocytes of ARA positive SSc patients.
Literature
1.
go back to reference Seibold JR (2001) In: Ruddy S, Harris ED Jr, Sledge CB (eds) Scleroderma and mixed connective tissue diseases, 6th edn. W.B. Saunders Company, Philadelphia, pp 1211–1239 Seibold JR (2001) In: Ruddy S, Harris ED Jr, Sledge CB (eds) Scleroderma and mixed connective tissue diseases, 6th edn. W.B. Saunders Company, Philadelphia, pp 1211–1239
3.
go back to reference Okano Y, Steen V, Medsger TA Jr (1993) Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119:1005–1013PubMed Okano Y, Steen V, Medsger TA Jr (1993) Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119:1005–1013PubMed
7.
go back to reference Cipriani P, Fulminis A, Pingiotti E, Marrelli A, Liakouli V, Perricone R, Pignone A, Matucci-Cerinic M, Giacomelli R (2006) Resistence to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis. J Rheumatol 33(10):2003–2014PubMed Cipriani P, Fulminis A, Pingiotti E, Marrelli A, Liakouli V, Perricone R, Pignone A, Matucci-Cerinic M, Giacomelli R (2006) Resistence to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis. J Rheumatol 33(10):2003–2014PubMed
8.
go back to reference Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
9.
go back to reference Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, Krieg T, Leroy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, Krieg T, Leroy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed
10.
go back to reference Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA Jr (2005) Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody. Arthritis Rheum 52:2425–2432. doi:10.1002/art.21232 PubMedCrossRef Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA Jr (2005) Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody. Arthritis Rheum 52:2425–2432. doi:10.​1002/​art.​21232 PubMedCrossRef
12.
go back to reference Gavrieli Y, Sherman Y, Ben Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 2:1044–1051 Gavrieli Y, Sherman Y, Ben Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 2:1044–1051
13.
go back to reference Sokal P, Rohlf FJ (1991) Biometry. W.H. Freeman, San Francisco Sokal P, Rohlf FJ (1991) Biometry. W.H. Freeman, San Francisco
14.
go back to reference Majone F, Zamboni D, Cozzi F, Montaldi A, Grypiotis P, Luisetto R, Favaro M, Tonello M, Ruffatti A (2006) Unstabilized DNA breaks in lymphocytes of patients with systemic sclerosis. Eur J Dermatol 16:258–261PubMed Majone F, Zamboni D, Cozzi F, Montaldi A, Grypiotis P, Luisetto R, Favaro M, Tonello M, Ruffatti A (2006) Unstabilized DNA breaks in lymphocytes of patients with systemic sclerosis. Eur J Dermatol 16:258–261PubMed
15.
go back to reference Majone F, Cozzi F, Tonello M, Olivieri S, Montaldi A, Favaro M, Visentin S, Luisetto R, Ruffatti A (2007) Unstabilized DNA breaks in lymphocytes of patients with different subsets of systemic sclerosis. Ann N Y Acad Sci 1108:240–248. doi:10.1196/annals.1422.026 PubMedCrossRef Majone F, Cozzi F, Tonello M, Olivieri S, Montaldi A, Favaro M, Visentin S, Luisetto R, Ruffatti A (2007) Unstabilized DNA breaks in lymphocytes of patients with different subsets of systemic sclerosis. Ann N Y Acad Sci 1108:240–248. doi:10.​1196/​annals.​1422.​026 PubMedCrossRef
16.
go back to reference Porciello G, Scarpato R, Storino F, Cagetti F, Marcolongo R, Migliore L, Ferri C, Galeazzi M (2002) The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results. Reumatismo 34:36–39 Porciello G, Scarpato R, Storino F, Cagetti F, Marcolongo R, Migliore L, Ferri C, Galeazzi M (2002) The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results. Reumatismo 34:36–39
17.
go back to reference Porciello G, Scarpato R, Ferri C, Storino F, Cagetti F, Morozzi G, Bellisai F, Migliore L, Marcolongo R, Galeazzi M (2003) Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud’s phenomenon. J Rheumatol 30:1244–1247PubMed Porciello G, Scarpato R, Ferri C, Storino F, Cagetti F, Morozzi G, Bellisai F, Migliore L, Marcolongo R, Galeazzi M (2003) Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud’s phenomenon. J Rheumatol 30:1244–1247PubMed
18.
go back to reference Porciello G, Scarpato R, Storino F, Migliore L, Ferri C, Cagetti F, Morozzi G, Bellisai F, Marcolongo R, Galeazzi M (2004) Chromosome aberrations in Raynaud’s phenomenon. Eur J Dermatol 14:327–331PubMed Porciello G, Scarpato R, Storino F, Migliore L, Ferri C, Cagetti F, Morozzi G, Bellisai F, Marcolongo R, Galeazzi M (2004) Chromosome aberrations in Raynaud’s phenomenon. Eur J Dermatol 14:327–331PubMed
19.
Metadata
Title
Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis
Authors
Franca Majone
Silvia Olivieri
Franco Cozzi
Anna Montaldi
Marta Tonello
Maria Serena Visentin
Luca Ciprian
Amelia Ruffatti
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0799-x

Other articles of this Issue 8/2009

Rheumatology International 8/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.